Company Legal Name
Latest Valuation
Founded Year
Headquarters
HistoSonics Inc. develops advanced medical devices that non-invasively destroy tumors using focused ultrasound technology combined with real-time imaging guidance. Based in Plymouth, United States, the company specializes in histotripsy, a precise therapeutic approach that mechanically breaks down targeted tissue without thermal damage to surrounding healthy areas. This innovative platform offers physicians a minimally invasive alternative to traditional surgical procedures and radiation therapy for tumor treatment. HistoSonics' technology represents a significant advancement in non-invasive oncology treatments, positioning the company at the forefront of next-generation therapeutic ultrasound solutions for cancer care applications.
Availability of information and platform features may vary by region and applicable requirements.
Eligibility and access may depend on user location, verification status, and applicable legal or regulatory requirements.
Additional platform details may be available after account creation, where applicable.
Identity, compliance, and other review steps may be required before access to certain materials or features.
Platform details, if applicable, should be reviewed in account materials before making any decision.
Any economic terms, if applicable, should be reviewed carefully in the relevant materials.
Private market interests may be illiquid, restricted, or difficult to transfer. Users should not assume that any secondary market will be available.
Valuations may reflect past financing rounds or other available information and may not represent a price at which any person can transact.
Company and sector risks may vary by business model, technology development, competition, regulation, and market conditions.
Operational, documentation, custody, or verification processes may involve limitations, delays, or dependencies.
Regulatory, tax, and legal requirements may change and may affect information availability, platform features, or user eligibility.
